Viewing Study NCT00350792


Ignite Creation Date: 2025-12-24 @ 3:49 PM
Ignite Modification Date: 2026-01-12 @ 7:12 AM
Study NCT ID: NCT00350792
Status: COMPLETED
Last Update Posted: 2010-10-13
First Post: 2006-07-10
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Pemetrexed/Carboplatin Non-Small Cell Lung Cancer (NSCLC) Elderly Patients
Sponsor: Eli Lilly and Company
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 9941
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Chief Medical Officer
Old Organization: Eli Lilly

Collaborators